Gelnique is a prescription skin gel that is used to treat symptoms of an overactive bladder. This eMedTV article offers a complete overview of this drug, including information on how it works, possible side effects, and tips for when and how to use it.
Common side effects of Gelnique may include a dry mouth, fatigue, and dizziness. This eMedTV Web resource outlines other possible side effects of the drug, and describes which side effects are potentially serious and may require medical attention.
A healthcare provider may prescribe Gelnique to adults who have an overactive bladder. This part of the eMedTV Web site describes the uses of Gelnique in more detail. This page also explains how the medicine works and whether there are off-label uses.
As this page from the eMedTV site explains, the standard dosage of Gelnique for treating an overactive bladder is one packet of gel applied to the skin once daily. This article also offers suggestions on when and how to effectively use this medication.
Pramlintide, anticholinergic drugs, and acetylcholinesterase inhibitors may interact with Gelnique. This eMedTV Web article describes the possible side effects or complications that may develop with these and other drug interactions.
Before taking Gelnique, tell your doctor if you have glaucoma, liver disease, or any allergies. This eMedTV Web article contains other warnings and precautions for Gelnique, and includes important information on who should not take the medication.
This eMedTV page explains that vomiting, disorientation, and difficulty passing urine are among the possible signs of a Gelnique (oxybutynin gel) overdose. This page also describes possible treatment options that are available for an overdose.
As this eMedTV page explains, it is probably safe for pregnant women to use Gelnique (oxybutynin gel), although the full risks are not currently known. This page explores this topic in more detail, including the results of animal studies done on the drug.
At this time, it is not known whether Gelnique (oxybutynin gel) passes through breast milk in humans. This eMedTV resource offers more information on breastfeeding and Gelnique, and discusses the importance of talking to your doctor about your situation.
Patents currently prevent any generic Gelnique (oxybutynin gel) from being manufactured in the US. As this eMedTV Web resource explains, the first patent expires in 2020, at which point generic versions of the drug may become available.
